^
    BIOMARKER:

    ALK wild-type

    i
    Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor




    Show legend

    Include preclinical:
    Non Small Cell Lung Cancer
    Lung Non-Squamous Non-Small Cell Cancer
    Lung Non-Small Cell Squamous Cancer
    Lung Cancer
    cemiplimab-rwlc
    atezolizumab
    nivolumab + bevacizumab
    nivolumab + ipilimumab
    durvalumab + tremelimumab
    tislelizumab
    nivolumab
    durvalumab
    toripalimab-tpzi
    anlotinib + sintilimab
    AK112
    sintilimab
    pucotenlimab
    anlotinib + cadonilimab
    crizotinib